Evidence map›Paper›PMID 35419306›Full record

ArticleJournal of cancer prevention2022

Protocatechuic Acid, a Gut Bacterial Metabolite of Black Raspberries, Inhibits Adenoma Development and Alters Gut Microbiome Profiles in

Athena Dong, Chien-Wei Lin, Carla Elena Echeveste, Yi-Wen Huang, Kiyoko Oshima, Martha Yearsley, Xiao Chen, Jianhua Yu, Li-Shu Wang

Open access · diamondAbstract read
In one paragraph

Article in Journal of cancer prevention, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Cholesterol-Lowering Effect of Polysaccharides fromFoods (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Athena DongDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, WI, USA.ORCID https://orcid.org/0000-0002-9195-9107
Chien-Wei LinDivision of Biostatistics, Medical College of Wisconsin, WI, USA.ORCID https://orcid.org/0000-0003-4023-7339
Carla Elena EchevesteDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, WI, USA.ORCID https://orcid.org/0000-0001-8442-0683
Yi-Wen HuangDepartment of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID https://orcid.org/0000-0001-9220-8770
Kiyoko OshimaDepartment of Pathology, Johns Hopkins University, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-3357-6247
Martha YearsleyDepartment of Pathology, The Ohio State University, Columbus, OH, USA.ORCID https://orcid.org/0000-0003-0352-1277
Xiao ChenDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, WI, USA.ORCID https://orcid.org/0000-0003-3777-5304
Jianhua Yu *Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.ORCID https://orcid.org/0000-0002-0326-3223
Li-Shu Wang *Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, WI, USA.ORCID https://orcid.org/0000-0002-6500-6943
Medical College of Wisconsin · USCity Of Hope National Medical Center · USJohns Hopkins University · USThe Ohio State University · US

Funding

Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK CellsR01CA247550 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI YU, JIANHUA · 2020 to 2024
$2.2M
Elucidate and Modulate Cell Signaling in NK Cells for Glioma TreatmentR01AI129582 · NIAID · OHIO STATE UNIVERSITY · PI YU, JIANHUA · 2017 to 2021
$2.1M
Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-CadherinR01NS106170 · NINDS · OHIO STATE UNIVERSITY · PI YU, JIANHUA · 2018 to 2023
$1.9M
Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint InhibitorsR01CA266457 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI VILLALONA, MIGUEL A, YU, JIANHUA · 2022 to 2025
$1.8M
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer PreventionR01CA185301 · NCI · OHIO STATE UNIVERSITY · PI CALIGIURI, MICHAEL A, YU, JIANHUA · 2015 to 2019
$1.8M
Mechanisms of tumor suppressor gene reactivation in colon cancer by berriesR01CA148818 · NCI · OHIO STATE UNIVERSITY · PI WANG, LI-SHU · 2010 to 2014
$1.5M
scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid LeukemiaR21CA223400 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI YU, JIANHUA · 2019 to 2020
$414k
NCI NIH HHS R01 CA148818NCI NIH HHS R01 CA185301NCI NIH HHS R01 CA247550NCI NIH HHS R01 CA266457NCI NIH HHS R21 CA223400NIAID NIH HHS R01 AI129582NINDS NIH HHS R01 NS106170
6 · The paper itself

Abstract

Administration of black raspberries (BRBs) and their anthocyanin metabolites, including protocatechuic acid (PCA), has been demonstrated to exert chemopreventive effects against colorectal cancer through alteration of innate immune cell trafficking, modulation of metabolic and inflammatory pathways, etc. Previous research has shown that the gut microbiome is important in the effectiveness of chemoprevention of colorectal cancer. This study aimed to assess the potency of PCA versus BRB dietary administration for colorectal cancer prevention using an

Indexed as

APCColorectal neoplasmsGastrointestinal microbiomeGenesRubus

Identifiers

PMID35419306
PMCPMC8984655
OpenAlexW4224077869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.